ArticleMediators of inflammation2026
Salidroside and Hongjingtian Injection Inhibit the Onset and Progression of Asthma via Pyroptosis in the Ozone-Exposed Inflammation Environment.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Salidroside and Hongjingtian Injection Inhibit the Onset and Progression of Asthma via Pyroptosis in the Ozone-Exposed Inflammation Environment.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOzone is a common air pollutant, and exposure to high concentrations of ozone can promote the onset and progression of asthma. Pyroptosis is a form of cell death associated with asthma exacerbation.
methodsThis study aimed to identify ozone-related pyroptosis genes through network toxicology and RNA-seq analysis and to investigate the role of pyroptosis genes in asthma using multiple asthma tissue samples and machine learning methods. Key pyroptosis genes with significant roles in asthma were identified through experiments and multiomics approaches. Using network pharmacology methods, we screened traditional Chinese medicine (TCM) components associated with key pyroptosis genes. Through molecular clustering and molecular docking, we explored the interaction between TCM components and key genes. Using animal model drug interventions, we further analyzed the therapeutic effects of TCM components targeting pyroptosis on asthma under ozone exposure.
resultsThis study identified 16 ozone-related pyroptosis genes through network pharmacology and transcriptomics data analysis. Based on multiple asthma tissue samples and machine learning methods, the 16 pyroptosis genes were found to have diagnostic predictive roles in asthma. Through experimentation and multiomics approaches, gasdermin D (GSDMD) was identified as a key gene in exacerbating asthma under ozone exposure. Furthermore, scRNA-seq and virtual knockout revealed that GSDMD exerts a pro-inflammatory effect on the asthma microenvironment. Using network pharmacology methods, we screened for salidroside, a Chinese herbal component related to GSDMD. Through molecular clustering and molecular docking, we identified seven salidroside analogs in Hongjingtian injection (HJT). Using an animal model drug intervention, we further analyzed the intervention effects of salidroside and HJT on asthma under ozone exposure.
conclusionsOzone promotes the onset and progression of asthma by exacerbating inflammation and pyroptosis. salidroside and its analogs can target GSDMD to inhibit asthma exacerbation in ozone-induced inflammation environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.